Cardiac cachexia is associated with right ventricular failure and liver dysfunction

International Journal of Cardiology

Volumn 169, Issue 3, 2013, Pages 219-224

  Valentova, Miroslava ^a,b   Von Haehling, Stephan ^a   Krause, Christian ^a   Ebner, Nicole ^a   Steinbeck, Lisa ^a   Cramer, Larissa ^a   Doehner, Wolfram ^a   Murin, Jan ^b   Anker, Stefan D ^a   Sandek, Anja ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FACULTY HOSPITAL   (Slovakia)

Author keywords

Cardiac cachexia; Chronic heart failure; Liver function tests; Right heart function

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CACHEXIA; CARDIAC CACHEXIA; CARDIOVASCULAR PARAMETERS; CHOLESTASIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LIVER CONGESTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLE; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION;

CARDIAC CACHEXIA; CHRONIC HEART FAILURE; LIVER FUNCTION TESTS; RIGHT HEART FUNCTION;

AGED; CACHEXIA; CHOLESTASIS; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84887628708     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.134     Document Type: Article

References (40)

1. M. Muscaritoli, S.D. Anker, and J. Argilés Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics." Clin Nutr 29 2010 154 159
2. S. Fülster, M. Tacke, and A. Sandek Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF) Eur Heart J 34 2013 512 519
3. S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
4. L. Castillo-Martínez, A. Orea-Tejeda, and M.T. Rosales Anthropometric variables and physical activity as predictors of cardiac cachexia Int J Cardiol 99 2005 239 245
5. T. Tepsuwan, S. Schuarattanapong, S. Woragidpoonpol, S. Kulthawong, A. Chaiyasri, and W. Nawarawong Incidence and impact of cardiac cachexia in valvular surgery Asian Cardiovasc Thorac Ann 17 2009 617 621
6. S.D. Anker, T.P. Chua, and P. Ponikowski Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 1997 526 534
7. T.P. Braun, and D.L. Marks Pathophysiology and treatment of inflammatory anorexia in chronic disease J Cachexia Sarcopenia Muscle 1 2010 135 145
8. K. Sakuma, and A. Yamaguchi Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass J Cachexia Sarcopenia Muscle 3 2012 77 94
9. C.M. Hughes, J.V. Woodside, C. McGartland, M.J. Roberts, D.P. Nicholls, and P.P. McKeown Nutritional intake and oxidative stress in chronic heart failure Nutr Metab Cardiovasc Dis 4 2012 376 382
10. G.P. Arutyunov, O.I. Kostyukevich, R.A. Serov, N.V. Rylova, and N.A. Bylova Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure Int J Cardiol 125 2008 240 245
11. V.W.W. Tsai, Y. Husaini, and R. Manandhar Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15 J Cachexia Sarcopenia Muscle 3 2012 239 243
12. P. Meyer, G.S. Filippatos, and M.I. Ahmed Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure Circulation 121 2010 252 258
13. F. Haddad, R. Doyle, D.J. Murphy, and S.A. Hunt Right ventricular function in cardiovascular disease, part II: Pathophysiology, clinical importance, and management of right ventricular failure Circulation 117 2008 1717 1731
14. A. Sandek, J. Bauditz, and A. Swidsinski Altered intestinal function in patients with chronic heart failure J Am Coll Cardiol 50 2007 1561 1569
15. J.N. Johnson, D.J. Driscoll, and P.W. O'Leary Protein-losing enteropathy and the Fontan operation Nutr Clin Pract 27 2012 375 384
16. A. Sandek, I. Bjarnason, and H.-D. Volk Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure Int Journal Cardiol 157 2012 80 85
17. S.D. Anker, K.R. Egerer, H.D. Volk, W.J. Kox, P.A. Poole-Wilson, and A.J. Coats Elevated soluble CD14 receptors and altered cytokines in chronic heart failure Am J Cardiol 79 1997 1426 1430
18. R. Sharma, A.P. Bolger, and W. Li Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease Am J Cardiol 92 2003 188 193
19. M. Valentová, S. von Haehling, W. Doehner, J. Murín, S.D. Anker, and A. Sandek Liver dysfunction and its nutritional implications in heart failure Nutrition 29 2013 370 378
20. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
21. W.J. Evans, J.E. Morley, and J. Argilés Cachexia: a new definition Clin Nutr 27 2008 793 799
22. R.N. Baumgartner, K.M. Koehler, and D. Gallagher Epidemiology of sarcopenia among the elderly in New Mexico Am J Epidemiol 147 1998 755 763
23. M. Cesari, R.A. Fielding, and M. Pahor Biomarkers of sarcopenia in clinical trials - recommendations from the International Working Group on Sarcopenia J Cachexia Sarcopenia Muscle 3 2012 181 190
24. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
25. E. Grünig, A. Barner, and M. Bell Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011 Int J Cardiol 154 Suppl. 1 2011 S3 S12
26. M. Cicoira, S.D. Anker, and C. Ronco Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle J Cachexia Sarcopenia Muscle 2 2011 135 142
27. S.H. Kubo, B.A. Walter, D.H. John, M. Clark, and R.J. Cody Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics Arch Intern Med 147 1987 1227 1230
28. G.T. Lau, H.C. Tan, and L. Kritharides Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation Am J Cardiol 90 2002 1405 1409
29. L.A. Allen, G.M. Felker, and S. Pocock Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Eur J Heart Fail 11 2009 170 177
30. T.B. Horwich, K. Kalantar-Zadeh, R.W. MacLellan, and G.C. Fonarow Albumin levels predict survival in patients with systolic heart failure Am Heart J 155 2008 883 889
31. J.P. Araújo, P. Lourenço, F. Rocha-Gonçalves, A. Ferreira, and P. Bettencourt Nutritional markers and prognosis in cardiac cachexia Int J Cardiol 146 2011 359 363
32. R.F. Ritchie, G.E. Palomaki, L.M. Neveux, O. Navolotskaia, T.B. Ledue, and W.Y. Craig Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort J Clin Lab Anal 13 1999 273 279
33. S.D. Anker, and R. Sharma The syndrome of cardiac cachexia Int J Cardiol 85 2002 51 66
34. D.L. Battin, S. Ali, and A.U. Shahbaz Hypoalbuminemia and lymphocytopenia in patients with decompensated biventricular failure Am J Med Sci 339 2010 31 35
35. A. Hjalmarson, S. Goldstein, and B. Fagerberg Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA 283 2000 1295 1302
36. M. Dekleva, H.D. Düngen, and G. Goeblich Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure - CIBIS-ELD sub-study Aging Clin Exp Res 6 2012 675 681
37. A.J.S. Coats, V. Srinivasan, and J. Surendran The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design J Cachexia Sarcopenia Muscle 2 2011 201 207
38. K. Mori, H. Morisaki, and S. Yajima Beta-1 blocker improves survival of septic rats through preservation of gut barrier function Intensive Care Med 37 2011 1849 1856
39. R. Nijveldt, T. Germans, G.P. McCann, A.M. Beek, and A.C. van Rossum Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance study Eur Radiol 18 2008 2399 2405
40. M. Pavlicek, A. Wahl, and T. Rutz Right ventricular systolic function assessment: rank of echocardiographic methods vs. cardiac magnetic resonance imaging Eur J Echocardiogr 12 2011 871 880